CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,892,000 | 1,124,000 | 8,368,000 | 6,321,000 | 4,056,000 |
| Depreciation Amortization | 2,289,000 | 1,138,000 | 4,366,000 | 3,232,000 | 2,105,000 |
| Income taxes - deferred | -341,000 | -217,000 | -676,000 | -163,000 | 87,000 |
| Accounts receivable | 2,798,000 | 3,008,000 | -6,260,000 | -3,920,000 | -804,000 |
| Accounts payable and accrued liabilities | 1,191,000 | -1,410,000 | 3,618,000 | 2,466,000 | -118,000 |
| Other Working Capital | 2,882,000 | 2,721,000 | 15,000 | 6,059,000 | 6,791,000 |
| Other Operating Activity | -3,719,000 | -1,461,000 | 3,995,000 | 2,067,000 | 1,229,000 |
| Operating Cash Flow | $7,992,000 | $4,903,000 | $13,426,000 | $16,062,000 | $13,346,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -1,392,000 | N/A | N/A | N/A |
| PPE Investments | -1,343,000 | -705,000 | -3,031,000 | -2,120,000 | -1,575,000 |
| Net Acquisitions | -73,000 | -25,000 | -16,612,000 | -16,492,000 | -16,474,000 |
| Purchase Of Investment | -6,781,000 | N/A | -9,043,000 | -6,625,000 | -4,499,000 |
| Sale Of Investment | 4,418,000 | N/A | 7,729,000 | 5,547,000 | 3,640,000 |
| Other Investing Activity | 60,000 | 28,000 | 68,000 | 43,000 | 32,000 |
| Investing Cash Flow | $-3,719,000 | $-2,094,000 | $-20,889,000 | $-19,647,000 | $-18,876,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -200,000 | 2,519,000 | 5,200,000 | 5,000,000 | 6,000,000 |
| Debt Issued | 4,959,000 | N/A | 10,898,000 | 10,898,000 | 10,898,000 |
| Debt Repayment | -37,000 | -18,000 | -3,166,000 | -2,734,000 | -1,787,000 |
| Common Stock Issued | 228,000 | 203,000 | 277,000 | 242,000 | 120,000 |
| Common Stock Repurchased | -3,024,000 | -3,027,000 | -2,012,000 | -2,013,000 | -2,016,000 |
| Dividend Paid | -1,698,000 | -840,000 | -3,132,000 | -2,353,000 | -1,574,000 |
| Other Financing Activity | -206,000 | -64,000 | -5,382,000 | -5,385,000 | -5,289,000 |
| Financing Cash Flow | $22,000 | $-1,227,000 | $2,683,000 | $3,655,000 | $6,352,000 |
| Beginning Cash Position | 8,525,000 | 8,525,000 | 13,305,000 | 13,305,000 | 13,305,000 |
| End Cash Position | 12,820,000 | 10,107,000 | 8,525,000 | 13,375,000 | 14,127,000 |
| Net Cash Flow | $4,295,000 | $1,582,000 | $-4,780,000 | $70,000 | $822,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,992,000 | 4,903,000 | 13,426,000 | 16,062,000 | 13,346,000 |
| Capital Expenditure | -1,343,000 | -705,000 | -3,031,000 | -2,120,000 | -1,575,000 |
| Free Cash Flow | 6,649,000 | 4,198,000 | 10,395,000 | 13,942,000 | 11,771,000 |